|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.49 INR | +0.45% |
|
-1.58% | +50.08% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Manufacturing Pharmaceutical Formulations | 61.59M | 69.74M | 71.55M | 70.3M | 65.28M | |||||
Total Assets | 101M | 99.31M | 102M | 114M | 118M | |||||
Interest Expense | -865K | -755K | -523K | -372K | -424K | |||||
Income Tax Expense | 376K | 1.41M | 1.42M | 1.64M | 1.23M | |||||
CAPEX | -1.58M | -375K | - | - | -2.62M | |||||
EBT | 2.45M | 4.8M | 6M | 6.5M | 6.19M | |||||
D&A | 1.91M | 2.01M | 1.29M | 1.3M | 1.31M | |||||
Net Income | 2.08M | 3.39M | 4.57M | 4.87M | 4.97M |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 61.59M | 69.74M | 71.55M | 70.3M | 65.28M | |||||
Total Assets | 101M | 99.31M | 102M | 114M | 118M | |||||
Interest Expense | -865K | -755K | -523K | -372K | -424K | |||||
Income Tax Expense | 376K | 1.41M | 1.42M | 1.64M | 1.23M | |||||
D&A | 1.91M | 2.01M | 1.29M | 1.3M | 1.31M | |||||
CAPEX | -1.58M | -375K | - | - | -2.62M | |||||
Net Income | 2.08M | 3.39M | 4.57M | 4.87M | 4.97M | |||||
EBT | 2.45M | 4.8M | 6M | 6.5M | 6.19M |
- Stock Market
- Stocks
- COLINZ6 Stock
- Financials Colinz Laboratories Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
